Access the full text.
Sign up today, get DeepDyve free for 14 days.
Anna-Maria Pehserl, A. Ress, S. Stanzer, Margit Resel, M. Karbiener, Elke Stadelmeyer, V. Stiegelbauer, A. Gerger, C. Mayr, M. Scheideler, G. Hutterer, T. Bauernhofer, T. Kiesslich, M. Pichler (2016)Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells
International Journal of Molecular Sciences, 17
Fariba Karami, Samira Mohammadi-Yeganeh, Nairi Abedi, Ameneh Koochaki, V. Kia, M. Paryan (2016)Bioinformatics Prediction and In Vitro Analysis Revealed That miR‐17 Targets Cyclin D1 mRNA in Triple Negative Breast Cancer Cells
Chemical Biology & Drug Design, 87
Yi Ma, Haozheng Yang, B. Dong, Hanbing Zou, Yan Zhou, X. Kong, Yi-ran Huang (2014)Biphasic regulation of autophagy by miR-96 in prostate cancer cells under hypoxia
David Garcia, Daehyun Baek, C. Shin, G. Bell, Andrew Grimson, D. Bartel (2011)Weak Seed-Pairing Stability and High Target-Site Abundance Decrease the Proficiency of lsy-6 and Other miRNAs
Nature structural & molecular biology, 18
Kaiyuan Zhang, Yanlei Zhang, Chang Liu, Ying Xiong, Jiqiang Zhang (2014)MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential (review).
International journal of oncology, 45 3
T. Garzon-Muvdi, Antonella Mangraviti, D. Theodros, Eileen Kim, M. Yellin, H. Marsh, M. Lim (2016)337 Expansion of Dendritic Cells Using FLT3 Ligand to Treat Glioblastoma: A Preclinical Study.
Huan-xin Lin, Ting Dai, H. Xiong, Xiaohui Zhao, Xiuting Chen, Chunping Yu, Jun Li, Xi Wang, Libing Song (2010)Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a
PLoS ONE, 5
Tristan Mooij, Brandon Mccutcheon, A. Leontovich, I. Parney (2016)336 Small RNA Sequencing of Glioblastoma Multiforme Extracellular Vesicles.
Neurosurgery, 63 Suppl 1
J. Moreno-Moya, F. Vilella, C. Simón (2014)MicroRNA: key gene expression regulators.
Fertility and sterility, 101 6
Ana Kozomara, S. Griffiths-Jones (2013)miRBase: annotating high confidence microRNAs using deep sequencing data
Nucleic Acids Research, 42
Y. Khotskaya, Aarthi Goverdhan, Jia Shen, M. Ponz-Sarvisé, Shih-Shin Chang, Ming-Chuan Hsu, Yongkun Wei, W. Xia, Dihua Yu, M. Hung (2014)S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer.
American journal of translational research, 6 4
A. Ress, V. Stiegelbauer, E. Winter, D. Schwarzenbacher, T. Kiesslich, S. Lax, S. Jahn, A. Deutsch, T. Bauernhofer, H. Ling, H. Samonigg, A. Gerger, G. Hoefler, M. Pichler (2015)MiR‐96‐5p influences cellular growth and is associated with poor survival in colorectal cancer patients
Molecular Carcinogenesis, 54
Ling Deng, Jie Chen, X. Zhong, T. Luo, Yan Wang, Hui Huang, Li Yin, Y. Qiu, H. Bu, Q. Lv, Hong Zheng (2015)Correlation between Activation of PI3K/AKT/mTOR Pathway and Prognosis of Breast Cancer in Chinese Women
PLoS ONE, 10
J. Hausser, Philipp Berninger, Christoph Rodak, Yvonne Jantscher, S. Wirth, M. Zavolan (2009)MirZ: an integrated microRNA expression atlas and target prediction resource
Nucleic Acids Research, 37
I. Segatto, S. Massarut, R. Boyle, G. Baldassarre, David Walker, B. Belletti (2016)Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer
Aging (Albany NY), 8
Xuan Huang, W. Lv, Jian-hua Zhang, D. Lu (2014)miR‑96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer.
International journal of molecular medicine, 34 6
Peirao Li, Cheng Sheng, Lingling Huang, Hui Zhang, Lihua Huang, Zeneng Cheng, Qubo Zhu (2014)MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration
Breast Cancer Research : BCR, 16
E. Paplomata, R. O'Regan (2014)The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
Therapeutic Advances in Medical Oncology, 6
M. Paraskevopoulou, G. Georgakilas, N. Kostoulas, I. Vlachos, Thanasis Vergoulis, M. Reczko, Christos Filippidis, Theodore Dalamagas, A. Hatzigeorgiou (2013)DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
Nucleic Acids Research, 41
D. Betel, Manda Wilson, Aaron Gabow, D. Marks, C. Sander (2007)The microRNA.org resource: targets and expression
Nucleic Acids Research, 36
Xi Sun, L. Zhao, Q. Zou, Z. Wang (2014)Identification of MicroRNA Genes and their mRNA Targets in Festuca arundinacea
Applied Biochemistry and Biotechnology, 172
Yong Huang, Q. Zou, Xi Sun, L. Zhao (2014)Computational Identification of MicroRNAs and Their Targets in Perennial Ryegrass (Lolium perenne)
Applied Biochemistry and Biotechnology, 173
C. Cheung, S. Lun, G. Chung, C. Chow, Carman Lo, K. Choy, K. Lo (2016)MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma
BMC Cancer, 16
L. Mulrane, S. McGee, W. Gallagher, D. O’Connor (2013)miRNA dysregulation in breast cancer.
Cancer research, 73 22
J-F Zhang, J Liu, Y Wang, B Zhang (2016)Novel therapeutic strategies for patients with triple-negative breast cancer
OncoTargets and Therapy, 9
J. Piriyapongsa, Chaiwat Bootchai, C. Ngamphiw, S. Tongsima (2012)microPIR: An Integrated Database of MicroRNA Target Sites within Human Promoter Sequences
PLoS ONE, 7
Junfeng Zhang, Xiangjie Kong, Jia Li, Qifeng Luo, Xiao-yu Li, Lei Shen, Lei Chen, Lin Fang (2014)miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
Oncology reports, 31 3
C. Oliveras‐Ferraros, S. Cufí, A. Vázquez-Martín, Violeta Torres-Garcia, S. Barco, B. Martín-Castillo, J. Menéndez (2011)Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: Induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a
Cell Cycle, 10
Liang Chen, Youhuai Li, Yebo Fu, Jin Peng, Meng-Hsuan Mo, M. Stamatakos, C. Teal, R. Brem, A. Stojadinovic, M. Grinkemeyer, T. McCaffrey, Y. Man, S. Fu (2013)Role of Deregulated microRNAs in Breast Cancer Progression Using FFPE Tissue
PLoS ONE, 8
S. Eissa, M. Matboli, H. Shehata (2015)Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
Translational research : the journal of laboratory and clinical medicine, 165 3
Xuemei Sun, Chunlai Zhang (2015)MicroRNA-96 promotes myocardial hypertrophy by targeting mTOR.
International journal of clinical and experimental pathology, 8 11
G. Misso, M. Martino, G. Rosa, A. Farooqi, A. Lombardi, Virginia Campani, M. Zarone, Annamaria Gullà, P. Tagliaferri, P. Tassone, M. Caraglia (2014)Mir-34: A New Weapon Against Cancer?
Molecular Therapy. Nucleic Acids, 3
H. Abrahams, M. Gielissen, I. Schmits, C. Verhagen, M. Rovers, H. Knoop, H. Knoop (2016)Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors.
Annals of oncology : official journal of the European Society for Medical Oncology, 27 6
S. Griffiths-Jones, H. Saini, S. Dongen, Anton Enright (2007)miRBase: tools for microRNA genomics
Nucleic Acids Research, 36
Nathan Wong, Xiaowei Wang (2014)miRDB: an online resource for microRNA target prediction and functional annotations
Nucleic Acids Research, 43
T. Venkatesh, P. Suresh, R. Tsutsumi (2016)tRFs: miRNAs in disguise.
Gene, 579 2
Sheng-Da Hsu, Chia-Huei Chu, A. Tsou, Shu-Jen Chen, Hua-Chien Chen, P. Hsu, Y. Wong, Yi-Hsuan Chen, Gian-Hung Chen, Hsien-Da Huang (2007)miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes
Nucleic Acids Research, 36
Harsh Dweep, N. Gretz (2015)miRWalk2.0: a comprehensive atlas of microRNA-target interactions
Nature Methods, 12
Junfei Zhang, Jia Liu, Yu Wang, Bin ZhangOncotargets and Therapy Dovepress Novel Therapeutic Strategies for Patients with Triple-negative Breast Cancer
M. Fan, A. Sethuraman, Martin Brown, Wenlin Sun, L. Pfeffer (2014)Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer
Breast Cancer Research and Treatment, 146
S. Eissa, H. Azzazy, M. Matboli, S. Shawky, H. Said, Fatin Anous (2014)The Prognostic Value of Histidine-Rich Glycoprotein RNA in Breast Tissue Using Unmodified Gold Nanoparticles Assay
Applied Biochemistry and Biotechnology, 174
N. Matamala, M. Vargas, R. González-Cámpora, R. Miñambres, J. Arias, P. Menéndez, E. Andrés-León, G. Gómez-López, K. Yanowsky, J. Calvete-Candenas, L. Inglada-Perez, B. Martínez-Delgado, J. Benítez (2015)Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
Clinical chemistry, 61 8
D. Vishwamitra, Yong Li, Desiree Wilson, Roxsan Manshouri, Choladda Curry, B. Shi, X. Tang, A. Sheehan, I. Wistuba, P. Shi, H. Amin (2012)MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression.
The American journal of pathology, 180 5
Nengwang Yu, Shuai Fu, Yubao Liu, Zhonghua Xu, Yi Liu, Junwen Hao, Baocheng Wang, Ai-min Zhang (2015)miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression
Journal of Experimental & Clinical Cancer Research : CR, 34
Samira Mohammadi-Yeganeh, M. Paryan, S. Samiee, M. Soleimani, E. Arefian, K. Azadmanesh, E. Mostafavi, R. Mahdian, M. Karimipoor (2013)Development of a robust, low cost stem-loop real-time quantification PCR technique for miRNA expression analysis
Molecular Biology Reports, 40
Shuangni Yu, Zhaohui Lu, Chang-zheng Liu, Yun-xiao Meng, Yihui Ma, Wu-gan Zhao, Jianping Liu, Jia Yu, Jie Chen (2010)miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer.
Cancer research, 70 14
Chih-Hung Chou, Nai-Wen Chang, S. Shrestha, Sheng-Da Hsu, Yu-Ling Lin, Wei-Hsiang Lee, Chi-Dung Yang, Hsiao-Chin Hong, Ting-Yen Wei, Siang-Jyun Tu, Tzi-Ren Tsai, S. Ho, Ting-Yan Jian, Hsin‐Yi Wu, Pin-Rong Chen, Nai-Chieh Lin, Hsin-Tzu Huang, Tzu-Ling Yang, Chung-Yuan Pai, Chun-San Tai, Wen-Liang Chen, Chia-Yen Huang, Chun-Chi Liu, Shun-Long Weng, K. Liao, W. Hsu, Hsien-Da Huang (2015)miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database
Nucleic Acids Research, 44
Vikram Agarwal, G. Bell, Jin-Wu Nam, D. Bartel (2015)Predicting effective microRNA target sites in mammalian mRNAs
A. Gilam, J. Conde, D. Weissglas-Volkov, N. Oliva, E. Friedman, N. Artzi, N. Shomron (2016)Local microRNA delivery targets Palladin and prevents metastatic breast cancer
Nature Communications, 7
F. Huemer, R. Bartsch, M. Gnant (2014)The PI3K/AKT/MTOR Signaling Pathway: The Role of PI3K and AKT Inhibitors in Breast Cancer
Current Breast Cancer Reports, 6
D Massihnia, A Galvano, D Fanale, A Perez, M Castiglia, L Incorvaia, A Listì, S Rizzo, G Cicero, V Bazan (2016)Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway
Breast Cancer (TNBC), 8
I. Vlachos, M. Paraskevopoulou, D. Karagkouni, G. Georgakilas, Thanasis Vergoulis, Ilias Kanellos, I. Anastasopoulos, Sofia Maniou, K. Karathanou, Despina Kalfakakou, Athanasios Fevgas, Theodore Dalamagas, A. Hatzigeorgiou (2014)DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions
Nucleic Acids Research, 43
Marie Cargnello, J. Tcherkezian, Philippe Roux (2015)The expanding role of mTOR in cancer cell growth and proliferation.
Mutagenesis, 30 2
Yu Hu, Qin Zhu, L. Tang (2014)MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression
PLoS ONE, 9
D. Massihnia, A. Galvano, D. Fanale, A. Perez, M. Castiglia, L. Incorvaia, A. Listì, S. Rizzo, G. Cicero, V. Bazan, S. Castorina, A. Russo (2016)Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway
Sung-Eun Hong, Eun-Kyu Kim, Hyeon-Ok Jin, Hyun-Ah Kim, Jin Lee, J. Koh, H. Seol, Jong‐il Kim, I. Park, W. Noh (2013)S6K1 inhibition enhances tamoxifen-induced cell death in MCF-7 cells through translational inhibition of Mcl-1 and survivin
Cell Biology and Toxicology, 29
A. McGuire, James Brown, M. Kerin (2015)Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
Cancer Metastasis Reviews, 34
M. Laplante, D. Sabatini (2012)mTOR Signaling in Growth Control and Disease
Y. Katayama, M. Maeda, K. Miyaguchi, Shota Nemoto, M. Yasen, Shinji Tanaka, H. Mizushima, Y. Fukuoka, S. Arii, Hiroshi Tanaka (2012)Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling.
Oncology letters, 4 4
Yeting Hong, Hongwei Liang, Uzair-ur-Rehman, Yanbo Wang, Weijie Zhang, Yong Zhou, Song’an Chen, Mengchao Yu, Sufang Cui, Minghui Liu, Nan Wang, Chao Ye, Chihao Zhao, Yanqing Liu, Q. Fan, Chen-Yu Zhang, J. Sang, Ke Zen, Xi Chen (2016)miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer
Scientific Reports, 6
Zeinab Ahsani, Samira Mohammadi-Yeganeh, V. Kia, Hamzeh Karimkhanloo, N. Zarghami, M. Paryan (2017)WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma
Applied Biochemistry and Biotechnology, 181
A. Krek, Dominic Grün, Matthew Poy, Rachel Wolf, Lauren Rosenberg, E. Epstein, P. MacMenamin, I. Piedade, K. Gunsalus, M. Stoffel, N. Rajewsky (2005)Combinatorial microRNA target predictions
Nature Genetics, 37
Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer. Aberrant expression of genes in mTOR pathway and their targeting miRNAs plays an important role in TNBC. The aim of this study was to determine the expression of mTOR and S6K1 and their targeting miRNAs in breast cancer cell lines and clinical samples. miRNAs targeting 3′-UTR of mTOR and S6K1 mRNAs were predicted using bioinformatic algorithms. MDA-MB-231, MCF-7, and MCF-10A as well as 20 TNBC samples were analyzed for gene and miRNA expression using quantitative real-time PCR (RT-qPCR). A receiver operating characteristic (ROC) curve analysis was performed for evaluation of candidate miRNAs as diagnostic biomarkers. miR-96 and miR-557 targeting mTOR and S6K1 mRNAs, respectively, were selected, and miR-3182 was selected as the miRNA targeting both genes. The miRNAs were down-regulated in cell lines, while their target mRNAs were up-regulated. Similar findings were observed in clinical samples. The ROC curve analysis revealed decline in expression of these miRNAs. We suggest that miR-96, miR-557, and miR-3182 can be used as inhibitory agents for mTOR and S6K1 in TNBC-targeted therapy.
Applied Biochemistry and Biotechnology – Springer Journals
Published: Jun 4, 2018
Access the full text.
Sign up today, get DeepDyve free for 14 days.